Novel compound eases paralysis and activates nerve repair pathways in multiple sclerosis mouse model
A new derivative of a natural compound reduced symptoms associated with multiple sclerosis and promoted the central nervous system's regenerative pathways in a mouse model, report researchers at the University of Illinois Urbana-Champaign and collaborators at Keio University and Chiba University in Japan.
Researchers at the University of Illinois Urbana-Champaign and collaborators from Keio University and Chiba University in Japan have discovered a new compound, furapyrrodole (FP), that eases paralysis and activates nerve repair pathways in a multiple sclerosis mouse model. The compound promotes the central nervous system's regenerative pathways by activating a mitochondrial enzyme, CYB5R3, which regulates a cellular signaling pathway key for regeneration.
The study, published in Advanced Science, indicates that FP could be a promising drug candidate for further investigation as a potential treatment for MS and other neurological disorders.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.